Assessment and Management of Late-Life Depression
- 1 March 2014
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 44 (3), 131-137
- https://doi.org/10.3928/00485713-20140306-04
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Neuromodulation for treatment-resistant depressionF1000 Medicine Reports, 2012
- Pharmacotherapy for Late-Life DepressionBritish Journal of Psychology, 2011
- Problem-Solving Therapy and Supportive Therapy in Older Adults With Major Depression and Executive DysfunctionAmerican Journal of Psychiatry, 2010
- A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic DepressionArchives of General Psychiatry, 2009
- The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidityInternational Journal of Clinical Practice, 2007
- The effects of memory, attention, and executive dysfunction on outcomes of depression in a primary care intervention trial: the PROSPECT studyInternational Journal of Geriatric Psychiatry, 2007
- Selegiline Transdermal System in the Prevention of Relapse of Major Depressive DisorderJournal of Clinical Psychopharmacology, 2006
- A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”International Psychogeriatrics, 2005
- Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2004
- A Systematic Review of Antidepressant Placebo-Controlled Trials for Geriatric Depression: Limitations of Current Data and Directions for the FutureNeuropsychopharmacology, 2004